Greifswald, Germany

Ioannis Pavlidis

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ioannis Pavlidis. Retrieved from https://idiyas.com/inventor/ioannis-pavlidis-3fa4hk14

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ioannis Pavlidis: Innovator in Transaminase Technology

Introduction

Ioannis Pavlidis is a notable inventor based in Greifswald, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of mutant transaminases. His work has implications for various applications, including the production of amines.

Latest Patents

Pavlidis holds a patent for "Mutant transaminases as well as methods and uses relating thereto." This invention relates to a mutant transaminase that exhibits increased transaminase activity compared to the wild-type transaminase. The patent also covers a fusion protein that includes the transaminase, a polynucleotide coding for the transaminase, and a host cell containing the polynucleotide. Furthermore, it details methods for producing amines using the mutant transaminase or fusion protein.

Career Highlights

Ioannis Pavlidis is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His work at the company has allowed him to focus on innovative solutions in enzyme technology.

Collaborations

Pavlidis has collaborated with notable colleagues, including Steven Paul Hanlon and Hans Iding. These collaborations have contributed to the advancement of research in transaminase applications.

Conclusion

Ioannis Pavlidis is a prominent figure in the field of biochemistry, with a focus on mutant transaminases. His patent and work at Hoffmann-La Roche Inc. highlight his contributions to innovative biotechnological solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…